What it is: A market failure occurs when the supply of a good or service is insufficient to meet demand. This results in an inefficient distribution of resources among market participants. Under free market conditions, prices are determined almost exclusively by the forces of supply and demand.
NuvaRing is currently under the protection of a patent that prevents any generic NuvaRing from being manufactured in the United States. The first patent for NuvaRing currently expires in April 2018.This is the earliest possible date that a generic version of NuvaRing could become available. However, there are other circumstances that could come up to extend the exclusivity period of NuvaRing beyond 2018.This could include such things as other patents for specific NuvaRing uses or lawsuits.uvaRing is currently under the protection of a patent that prevents any generic NuvaRing from being manufactured in the United States. The first patent for NuvaRing currently expires in April 2018.
Patents currently prevent the manufacturing of any generic versions of Xarelto (rivaroxaban) at this time. The first patent is scheduled to expire in December 2020, which is the earliest date that generic versions could become available. However, lawsuits or other patents for new uses of the drug may delay the manufacturing of a generic Xarelto.